4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-22-060581
Chief Commercial Officer sold 382 shares at $15.79 ($6,032)
From the SEC's structured data for this filing
Trades in this filing
Wettig Thane · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-08 | Sale : show line 1 in the form | −382 | $15.79 | $6,032 | 89,897 | D |
| Open-market sales · 382 sh · avg $15.79 · $6,032 | ||||||
Loading xslF345X03/doc4.xml…